IRIDEX (IRIX) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
IRIDEX is the larger company by market cap ($15.6 million vs $3.0 million), about 5.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRIX | NXL |
|---|---|---|
| Share price | $0.89 | $3.63 |
| Market cap | $15.63M | $3.01M |
| 1-day change | -0.89% | -11.68% |
| YTD return | -21.93% | — |
| 1-year return | -20.54% | — |
| 5-year return | -87.99% | — |
| EPS (TTM) | $-0.20 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $50.70 |
| 52-week low | $0.61 | $3.50 |
| Distance from 52-week high | -46.06% | -92.84% |
| Analyst consensus | none | buy |
| Avg. price target upside | +208.99% | +313.22% |
| Average volume | 394.22K | 1.02M |
| Shares outstanding | 17.56M | 829.40K |
| Employees | 93 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRIDEX is about 5.2 times larger than Nexalin Technology by market value ($15.63M vs $3.01M).
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 93 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
IRIX vs NXL FAQ
Which is bigger, IRIDEX or Nexalin Technology?
IRIDEX (IRIX) is larger, with a market capitalization of $15.63M compared with $3.01M for Nexalin Technology (NXL).
Are IRIDEX and Nexalin Technology in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.